Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News In Brief

This article was originally published in The Silver Sheet

Executive Summary

Firms with an egregious state of quality control might be able to enter into remediation agreements with FDA; agency might ease up on direct marking of devices in final UDI rule; and more.

You may also be interested in...



Year In Review: Complaint Handling, UDI, FDA Inspections, And More

The top quality-related topics manufacturers faced last year included a new FDA regulation to track and trace devices, innovative supply chain initiatives and an update to the agency’s Medical Device Reporting guidance, among others. Plus honorable mentions: product recalls, human factors and FDA compliance meetings.

News In Brief

CDRH makes modifications to its product recalls database; new FDA pilot program aims to give manufacturers a chance to fix quality system problems; and more.

FDA Launches Voluntary Compliance Improvement Pilot

The Office of Compliance pilot aims to challenge companies with less-than-stellar quality systems to improve compliance at their facilities without undergoing an inspection.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel